Evofem Biosciences, Inc. (EVFM)
USD 0.01
(-6.25%)
USD 0.01
(-6.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 18.21 Million | 16.83 Million | 8.24 Million | 446 Thousand | - | - |
| Cost of Revenue | 6.51 Million | 4.41 Million | 4.05 Million | 468 Thousand | 905 Thousand | 262 Thousand |
| Gross Profit | 11.7 Million | 12.42 Million | 4.18 Million | -22 Thousand | -905 Thousand | -262 Thousand |
| Operating Expenses | 29.55 Million | 96.54 Million | 170.99 Million | 103.6 Million | 52.74 Million | 77.64 Million |
| Selling, General and Administrative Expenses | 26.61 Million | 71.51 Million | 137.86 Million | 86.55 Million | 30.51 Million | 34.22 Million |
| Research and Development Expenses | 2.93 Million | 25.03 Million | 33.12 Million | 17.05 Million | 22.23 Million | 43.41 Million |
| Other Expenses | - | -2.08 Million | -4.73 Million | -2.08 Million | -19.99 Million | -145 Thousand |
| Cost and Expenses | 36.06 Million | 100.96 Million | 175.04 Million | 104.07 Million | 52.74 Million | 77.64 Million |
| Operating Income | -17.84 Million | -84.12 Million | -166.8 Million | -103.62 Million | -52.74 Million | -77.64 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 17 Thousand | 44 Thousand | 17 Thousand | 4000.00 | 4000.00 | 2000.00 |
| Earnings before Tax | 52.99 Million | -76.65 Million | -205.17 Million | -142.3 Million | -80.02 Million | -125.71 Million |
| Net Income | 52.97 Million | -76.69 Million | -205.19 Million | -142.3 Million | -80.03 Million | -125.71 Million |
| Earnings Per Share Basic | 10.35 | -163.19 | -2931.31 | -3557.72 | -4001.65 | -10.76 Thousand |
| Earnings Per Share Diluted | 0.05 | -163.19 | -2931.31 | -3557.72 | -4001.65 | -10.76 Thousand |
| Weighted Average Shares Outstanding | 4.83 Million | 470 Thousand | 70 Thousand | 40 Thousand | 20 Thousand | 11.68 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 984.03 Million | 470 Thousand | 70 Thousand | 40 Thousand | 20 Thousand | 11.68 Thousand |
| Gross Margin | 0.64 | 0.74 | 0.51 | -0.05 | - | - |
| EBIT Margin | -0.95 | -5.56 | -16.15 | -149.90 | - | - |
| Profit Margin | 2.91 | -4.56 | -24.89 | -319.08 | - | - |
| EBITDA | -17.37 Million | -83.1 Million | -165.77 Million | -103.32 Million | -79.12 Million | -29.59 Million |
| Earnings Before Tax Margin | -0.98 | -5.00 | -20.23 | -232.34 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.16 Million | 3.6 Million | 4.83 Million | 18.21 Million | 5.11 Million | 2.45 Million |
| Cost of Revenue | 811 Thousand | 743 Thousand | 1.02 Million | 8.29 Million | 1.88 Million | 2.29 Million |
| Gross Profit | 3.34 Million | 2.86 Million | 3.81 Million | 9.92 Million | 3.22 Million | 165 Thousand |
| Operating Expenses | 4.73 Million | 5.7 Million | 7.19 Million | 27.77 Million | 6.77 Million | 7.5 Million |
| Selling, General and Administrative Expenses | 4.47 Million | 5.12 Million | 5.83 Million | - | 6.16 Million | 7.09 Million |
| Research and Development Expenses | 263 Thousand | 582 Thousand | 1.36 Million | - | 614 Thousand | 402 Thousand |
| Other Expenses | -558 Thousand | -3.89 Million | -587 Thousand | -2.62 Million | -596 Thousand | -1.12 Million |
| Cost and Expenses | 5.54 Million | 6.44 Million | 8.21 Million | 36.06 Million | 8.66 Million | 9.79 Million |
| Operating Income | -1.38 Million | -2.84 Million | -3.38 Million | -17.84 Million | -3.55 Million | -7.33 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 8000.00 | 15.72 Thousand | 23.18 Thousand | 17 Thousand | 11 Thousand | 3000.00 |
| Earnings before Tax | 1.35 Million | -4.8 Million | -2.11 Million | 52.99 Million | 66.01 Million | -8.55 Million |
| Net Income | 1.35 Million | -4.8 Million | -2.11 Million | 52.97 Million | 66 Million | -8.55 Million |
| Earnings Per Share Basic | 0.02 | -0.15 | -0.11 | - | 15.34 | -5.42 |
| Earnings Per Share Diluted | -0.00 | -0.15 | -0.11 | - | 0.10 | -5.42 |
| Weighted Average Shares Outstanding | 66.77 Million | 31.19 Million | 20.01 Million | 4.83 Million | 4.24 Million | 1.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.61 Billion | 31.19 Million | 20.01 Million | 984.04 Million | 729.98 Million | 1.58 Million |
| Gross Margin | 0.81 | 0.79 | 0.79 | 0.54 | 0.63 | 0.07 |
| EBIT Margin | -0.32 | -0.77 | -0.68 | - | -14.41 | -2.87 |
| Profit Margin | 0.32 | -1.33 | -0.44 | 2.91 | 12.91 | -3.48 |
| EBITDA | -1.34 Million | -2.78 Million | -3.31 Million | - | -73.67 Million | -7.06 Million |
| Earnings Before Tax Margin | -0.33 | -0.79 | -0.70 | -0.98 | -0.69 | -2.98 |
AAVC
FBPI
0691
OXM
BTDPF
5287